Applying evidence to patient care: From black and white to shades of grey

被引:19
作者
McAlister, FA [1 ]
机构
[1] Univ Alberta, Edmonton, AB T6G 2R7, Canada
关键词
D O I
10.7326/0003-4819-138-11-200306030-00016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This editorial focuses on the dilemma at the heart of Dr. Shlipak's paper in this issue: How can we extrapolate from trials conducted in highly selected patients to a broader population of patients who have the same condition but do not meet the trial eligibility criteria?
引用
收藏
页码:938 / 939
页数:2
相关论文
共 17 条
[1]  
[Anonymous], 1988, LANCET, V2, P349
[2]   Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].
Assmann, SF ;
Pocock, SJ ;
Enos, LE ;
Kasten, LE .
LANCET, 2000, 355 (9209) :1064-1069
[3]   Users' guides to the medical literature XIX. Applying clinical trial results A. How to use an article measuring the effect of an intervention on surrogate end points [J].
Bucher, HC ;
Guyatt, GH ;
Cook, DJ ;
Holbrook, A ;
McAlister, FA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08) :771-778
[4]   Principles from clinical trials relevant to clinical practice: Part I [J].
Califf, RM ;
DeMets, DL .
CIRCULATION, 2002, 106 (08) :1015-1021
[5]   Observations of the treatment of women in the United States with myocardial infarction - A report from the National Registry of Myocardial Infarction-I [J].
Chandra, NC ;
Ziegelstein, RC ;
Rogers, WJ ;
Tiefenbrunn, AJ ;
Gore, JM ;
French, WJ ;
Rubison, M .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (09) :981-988
[6]   Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients [J].
Flather, MD ;
Yusuf, S ;
Kober, L ;
Pfeffer, M ;
Hall, A ;
Murray, G ;
Torp-Pedersen, C ;
Ball, S ;
Pogue, J ;
Moyé, L ;
Braunwald, E .
LANCET, 2000, 355 (9215) :1575-1581
[7]   Representation of the elderly, women, and minorities in heart failure clinical trials [J].
Heiat, A ;
Gross, CP ;
Krumholz, HM .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) :1682-1688
[8]  
Massie B M, 1998, Lancet, V352 Suppl 1, pSI29, DOI 10.1016/S0140-6736(98)90016-2
[9]   Commentary: Relative treatment effects are consistent across the spectrum of underlying risks ... usually [J].
McAlister, FA .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (01) :76-77
[10]   Active-control equivalence trials and antihypertensive agents [J].
McAlister, FA ;
Sackett, DL .
AMERICAN JOURNAL OF MEDICINE, 2001, 111 (07) :553-558